New Pradaxa trials

November 26, 2013

Boehringer Ingelheim has announced plans for two new global clinical trials of its novel anticoagulant Pradaxa (dabigatran etexilate mesylate). One of the trials, RE-DUAL PCI is designed to evaluate the efficacy and safety of Pradaxa in patients with non-valvular atrial fibrillation who have undergone angioplasty with stent placement. And the other trial, RE-SPECT ESUS will look at Pradaxa’s efficacy and safety as a secondary stroke prevention therapy in patients who have suffered an embolic stroke of undetermined source. Both trials, which are planning to begin enrolment in 2014 and 2015 respectively, would add to the existing clinical trial program for Pradaxa which includes ten completed phase III trials involving about 40,000 patients.

The above article was sent to subscribers in Pharmacy Daily's issue from 26 Nov 13
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 26 Nov 13

Other recent headlines

WA group stocks vapes
Friday | Apr 26 2024

IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).

Fujitsu to protect against cyber threats
Friday | Apr 26 2024

FUJITSU has launched its new Trans-Tasman division, Cyber Security Services, to address growing online threats within the healthcare sector.

PD breaking news – Queensland pharmacies scope of practice pilot expanded
Wednesday | Apr 24 2024

Twenty-two additional health conditions added to Queensland pilot. The Pharmacy Guild of Australia Queensland Branch President…

SEARCH PHARMACY DAILY

Featured video
MORE VIDEOS

Recent issues

PD for Fri 26 Apr 2024
PD for Wed 24 Apr 2024
PD for Tue 23 Apr 2024
PD for Mon 22 Apr 2024
PD for Fri 19 Apr 2024
SEE MORE ISSUES

INDUSTRY JOB VACANCIES

Pharmacist in Charge – SA
Pharmacist Manager – WA
Compounding Pharmacist – Melbourne
Pharmacist in Charge – QLD North
Pharmacist – Sydney North
SEE MORE JOBS

Pharmacy Daily is Australia's favourite online publication dedicated to the pharmacy industry. The publication launched in March 2007 and is distributed every day by email to pharmacists across the country.

PHARMACY DAILY NEWS
Headlines

Jobs

New Products

Events Calendar

FEEDS
News Items RSS feed

PD Issues RSS feed

All content RSS feed

Content & Media
Pharmacy Daily TV

OUR SITES
Sitemap

Travel Daily

Travel Bulletin

Cruise Weekly

Business Events News

Pharmacy Daily

ADVERTISE WITH US
Advertise in Pharmacy Daily

Privacy

ADMIN
Log in

SUBSCRIBE
Sign up for FREE

Subscription Information

"Water, air, and cleanness are the chief articles in my pharmacy." - Napoleon Bonaparte

Copyright © 2018 Pharmacy Daily

Subscribe to Pharmacy Daily now!

FREE Pharmacy Daily subscription - never miss another story!

Name*
First Last
Email*

Profession
Company

Address
City State / Province / Region ZIP / Postal Code Country

By submitting this form I hereby certify that I understand that Pharmacy Daily is a publication for health professionals.
Email
This field is for validation purposes and should be left unchanged.

to top

Pharmacy Daily | New Pradaxa trials

New Pradaxa trials

Other recent headlines

WA group stocks vapes

Fujitsu to protect against cyber threats

PD breaking news – Queensland pharmacies scope of practice pilot expanded

SEARCH PHARMACY DAILY

Featured video

Recent issues

INDUSTRY JOB VACANCIES